INBX filings
Corporate insider profile
Mark Lappe Filing Activity
Latest reported as Chief Executive Officer of Inhibrx Biosciences, Inc. (INBX).
- Purchase filings
- 2
- Reported companies
- 1
- Net open-market value
- $3,644,184
- Latest transaction
- Sep 28, 2026
Affiliated corporations
Reported company relationships
Transaction history
